top of page

Using AI to Augment and Accelerate Life Sciences Innovation

  • Writer: Mike J. Walker
    Mike J. Walker
  • Dec 3, 2025
  • 4 min read

In a recent conversation on the podcast VITALS: The Pulse of Georgia Life Sciences, I sat down with Maria Thacker Goethe, President & CEO of Georgia Life Sciences, to explore how AI can empower small and mid-size biotech companies right now. What emerged wasn’t hype but rather a practical, high-impact strategies that can meaningfully accelerate innovation, compliance, and growth.


Here's a summary of the conversation and a few additional thoughts. Enjoy!


Using AI to Augment and Accelerate Life Sciences Innovation

When most people picture artificial intelligence in life sciences, they envision lab robots, drug-discovery algorithms, or futuristic bio-engineering. But the real revolution is happening behind the scenes in the often-overlooked world of documentation, compliance, regulatory filings, and operational workflows. You know, the not so sexy use cases but provide huge financial returns operationally.


From “Boring Paperwork” to Business Accelerator

Most companies don’t need flashy AI agents or sci-fi-style automation. What they need are tools that reduce friction. This can range from manually writing standard operating procedures (SOPs), to assembling regulatory submissions, to streamlining quality-control documentation.


Mike J Walker: AI Automating Boring SOPs in Life Sciences
Example of a Standard Operating Procedure (SOP) with its highly structured content and high data quality.

These “non-sexy” AI applications:

  • Attract and retain talent

  • Save time and headcount

  • Improve consistency, quality, and reduce deviations caused by human error.

  • Free your talent to focus on science, not paperwork.


For many bippharma,biotech, and med-device firms, this shift isn’t just nice-to-have, it’s a potential competitive advantage. 


Smart and Practical First Steps with AI in Life Sciences

Mike J Walker: Smart and Practical First Steps with AI in Life Sciences

AI adoption in life sciences doesn’t begin with moonshots. It begins with small, high-value, low-risk steps that build momentum and credibility inside the organization. Below are the most practical starting points.


1. Start small and focus on high-ROI areas

Don’t chase advanced autonomous agents immediately. Instead, consider tools for document generation, SOP standardization, regulatory submission preparation, and internal reports. These tasks often consume 30–50% of scientific and quality staff time. By mitgating this with AI, organization can deliver clear ROI and deliver processes that are easier to govern.


These are great starting points because they:

  • Have a clear structure

  • Heavy repetition

  • High documentation burden

  • Low risk when human review is maintained

  • Immediate time-savings



2. Upskill your existing workforce and bring in new talent

AI will only pay off if people know how to use it. Encourage upskilling across teams, and consider hiring “AI-digital natives” to shadow existing employees, bringing fresh perspectives and best practices. For those existing employees, AI tools succeed when people know how to apply them., this requires:

  1. Lightweight training programs

  2. Role-specific enablement (e.g., for QC analysts, QA reviewers, regulatory writers)

  3. Mentorship loops: pairing senior SMEs with AI-digital-native newcomers


When I advise clients, I suggest the following practical approaches:

  • Weekly “AI office hours” in each function (Quality, Regulatory, Manufacturing).

  • Internal champions who document wins and spread best practices.

  • Bringing in younger talent already fluent with AI tools to accelerate cultural change.


3. Build trust and governance from day one

Regulated industries require traceability, explainability, audit-ready logs, and a zero-trust posture. Building trust early avoids roadblocks later. Use a zero-trust data architecture, clear audit trails, governance policies, and fallback systems to ensure integrity and regulatory readiness. 


Some of the first things I recommend to put in place early are:

  1. Approval workflows. AI-generated content must always have a human approver.

  2. Audit logging. Track who used AI, inputs, outputs, and changes.

  3. Context boundaries. Ensure models only touch allowed datasets.

  4. Version control. Approved AI-generated documents should have immutable historical versions.


4. Democratize AI adoption — treat tools like apps in a marketplace

Make AI tools accessible to all functions (lab teams, quality, regulatory, ops). Non-technical employees should be able to use AI tools without knowing how models work. Think: one-click apps for everyday tasks. The easier and more familiar they feel, the faster they’ll be adopted across the company.


Examples of “AI Apps” to Offer Internally

  • SOP Generator

  • Deviation Summarizer

  • Regulatory Content Extractor

  • Batch-Record Analyzer

  • Training Material Generator

  • Meeting Notes → Action Items Converter


Each app focuses on a single job to be done, making adoption frictionless.


5. Build for growth and create a future-ready digital backbone

Every small step should feed into a larger long-term architecture. Companies who build this foundation now will be able to scale faster, innovate faster, onboard AI agents safely, attract modern digital talent, and outperform competitors by years, not months.


AI today lays the groundwork for:

  • Agentic automation

  • Digital twins

  • Biohacking risk detection

  • Quantum-accelerated simulation

  • Intelligent operations



Thinking Long-Term: Building the “Factory of the Future”

Mike J Walker: Thinking Long-Term: Building the “Factory of the Future”

AI is just the start. Technologies like AGI, quantum computing and biohacking are on the horizon and could radically reshape how drugs are developed, regulated, and manufactured. Savvy companies (and forward-thinking states) should already begin defining what their “future-ready” manufacturing and development facilities look like. Use today’s AI infrastructure as a foundation for tomorrow’s breakthroughs.


If you’re part of a small or mid-size biotech or medical-device company, AI should be one of your top strategic levers — not as a speculative gamble, but as a practical tool to accelerate compliance, innovation, and growth. The future belongs to those who adopt intelligently, build responsibly, and design for long-term resilience.



 
 
 

Subscribe Form

Thanks for submitting!

  • Twitter
  • LinkedIn

©2026  Mike J. Walker., LLC

bottom of page